Form D · Biotechnology

VitaPath Genetics, Inc.

Foster City, CA · CIK 0001526650

Offering snapshot reported Aug 6, 2012 · SEC filing

Reported sold: $5.04M
Investors reported: 7
Minimum accepted: $0
First sale: Apr 26, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,710,428 → $5,037,974
Reported investors3 → 7

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 6, 2012	Amendment	$5,037,974	$327,546vs May 10, 2012	7	SEC filing
May 10, 2012	Initial	$4,710,428	No comparison	3	SEC filing
Aug 12, 2011	Initial	$4,152,504	No comparison	3	SEC filing

Offering details

Securities: Equity, Other
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-178042

Series C Preferred Stock; Common Stock issuable upon conversion thereof

Source: Form D, filed Aug 6, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Borrus	Director
Catherine M. Burzik	Director
Rowan Chapman	Director
Bruce Cohen	Director, Executive
Dennis Gilbert	Director, Executive
Girish Putcha	Executive
Jasper Rine	Director, Executive
Richard Taylor	Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

348 Hatch Drive
Foster City, CA, 94404